货号:GS40607
Rilotumumab is a fully human monoclonal antibody targeting hepatocyte growth factor (HGF). It binds to HGF to prevent its interaction with the c-Met receptor, thereby inhibiting the HGF/c-Met signaling pathway involved in tumor growth, angiogenesis, and metastasis. It was investigated for the treatment of advanced solid tumors such as gastric cancer and glioblastoma.
科技型中小企业
高新技术企业
武汉迈思生物科技有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!
冉凯凯